Variant report
Variant | nsv983729 |
---|---|
Chromosome Location | chr13:85379122-85428478 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:85418682..85419230-chr13:86438823..86439343,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs115779455 | chr13:85384241-85384242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563323024 | chr13:85384316-85384317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573547706 | chr13:85384325-85384326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540672072 | chr13:85384333-85384334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530420560 | chr13:85384346-85384347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs145592472 | chr13:85384398-85384399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544778856 | chr13:85384423-85384424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs147714400 | chr13:85384445-85384446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556720670 | chr13:85384456-85384457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530768847 | chr13:85384487-85384488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142484896 | chr13:85384506-85384507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528126645 | chr13:85384573-85384574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561286218 | chr13:85384648-85384649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192540680 | chr13:85384699-85384700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10781935 | chr13:85384799-85384800 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs566128982 | chr13:85384800-85384801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs80107442 | chr13:85384810-85384811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs571737046 | chr13:85384821-85384822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532674298 | chr13:85384838-85384839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111528682 | chr13:85384843-85384844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs9670314 | chr13:85384844-85384845 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs80213179 | chr13:85384846-85384847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs184724691 | chr13:85384865-85384866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs112831313 | chr13:85384873-85384874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs548597855 | chr13:85384894-85384895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114313563 | chr13:85384987-85384988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534278146 | chr13:85384992-85384993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150217560 | chr13:85385016-85385017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs74442676 | chr13:85385050-85385051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs12017137 | chr13:85385072-85385073 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs558167221 | chr13:85385074-85385075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79989963 | chr13:85385084-85385085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs553653695 | chr13:85385087-85385088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs9743334 | chr13:85385093-85385094 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs542813790 | chr13:85385099-85385100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560986485 | chr13:85385116-85385117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs573191847 | chr13:85385117-85385118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540602570 | chr13:85385130-85385131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78645480 | chr13:85385142-85385143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537451978 | chr13:85385144-85385145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148921078 | chr13:85385161-85385162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532582582 | chr13:85385166-85385167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs371395818 | chr13:85385177-85385178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550785190 | chr13:85385207-85385208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563045670 | chr13:85385214-85385215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555093914 | chr13:85385215-85385216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs143609659 | chr13:85385222-85385223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs548772879 | chr13:85385233-85385234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186869478 | chr13:85385251-85385252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs138155828 | chr13:85385253-85385254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Osteosarcoma | 21215367 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:85384200-85385200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr13:85384600-85385000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr13:85384600-85385200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr13:85384600-85385200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr13:85384600-85385400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr13:85384600-85385400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr13:85385400-85386200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
8 | chr13:85386200-85386400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr13:85391000-85391400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr13:85391000-85391400 | Enhancers | Fetal Heart | heart |
11 | chr13:85391000-85391600 | Enhancers | H1 Cell Line | embryonic stem cell |
12 | chr13:85391000-85391600 | Enhancers | H9 Cell Line | embryonic stem cell |
13 | chr13:85391400-85395400 | Weak transcription | Fetal Heart | heart |
14 | chr13:85395400-85395800 | Enhancers | Fetal Heart | heart |
15 | chr13:85404400-85404600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
16 | chr13:85404600-85405800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr13:85405800-85406000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr13:85405800-85406400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
19 | chr13:85406000-85406600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr13:85406600-85406800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
21 | chr13:85406600-85406800 | Bivalent/Poised TSS | Fetal Adrenal Gland | Adrenal Gland |
22 | chr13:85419600-85420800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
23 | chr13:85427800-85432600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |